Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-28 Sale |
2025-03-04 4:59 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
583 | $4.75 | $2,769 | 13,109 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 7:15 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
372 | $4.72 | $1,756 | 13,692 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-06 4:51 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
3,668 | $0.29 | $1,064 | 168,768 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 4:05 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
4,149 | $0.35 | $1,452 | 172,436 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-06 4:15 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
3,936 | $0.75 | $2,952 | 176,585 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:19 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
5,834 | $0.89 | $5,192 | 180,521 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 5:10 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
35,575 | $0.53 | $18,855 | 186,355 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 4:26 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
4,981 | $0.55 | $2,740 | 221,930 (Direct) |
View |
| 2023-11-02 Sale |
2023-11-03 4:37 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
3,796 | $1.22 | $4,631 | 164,411 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-04 5:21 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
4,307 | $3.07 | $13,222 | 168,207 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 4:22 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
3,869 | $4.4 | $17,024 | 172,514 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 4:47 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
5,987 | $9.71 | $58,134 | 176,383 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 6:38 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
4,191 | $11.8 | $49,454 | 182,370 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 5:23 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
14,470 | $11.13 | $161,051 | 186,561 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 5:48 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
2,006 | $12.67 | $25,416 | 201,031 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-07 7:33 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
2,304 | $13.04 | $30,044 | 26,896 (Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 8:28 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
2,000 | $15.82 | $31,638 | 11,200 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Option Award |
2024-02-05 4:26 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
62,500 | $0 | 221,930 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:35 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2022-11-30 4:40 pm |
N/A 2032-11-27 |
KEMPHARM INC | KMPH | Posner Christopher Director |
0 | $0 | 22,500 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:17 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
160,000 | $0 | 324,037 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-03 08:15 am |
N/A 2031-10-29 |
Cara Therapeutics Inc. | CARA | Posner Christopher Senior Advisor |
713,941 | $0 | 730,037 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 7:33 pm |
N/A 2031-06-03 |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
18,000 | $0 | 26,896 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:46 pm |
N/A 2030-06-04 |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
18,000 | $0 | 24,000 (Direct) |
View |